By Ana Espino | Published on July 21, 2025 | 2 min read
#SkinCondition #EO #Formulations
#Dermatology #DDS
Skin conditions are an increasing
health concern, both in medical dermatology and therapeutic cosmetics. These
disorders require
treatments that meet several demands: therapeutic efficacy,
local tolerance, and the ability to reach the deep layers of the epidermis
without damaging the skin barrier. In this context, plant-derived
essential
oils (EOs) are regaining attention due to their
rich and multifunctional
pharmacological profile. Numerous studies have highlighted their antimicrobial,
anti-inflammatory, antioxidant, and healing properties, making EOs promising
candidates for managing skin disorders.
However, their clinical use remains
limited due to
major challenges: high volatility, chemical instability, and low
cutaneous bioavailability. When applied in
pure form or poorly formulated, some
EOs can also
trigger irritant or allergenic reactions, limiting their long-term
safety. These limitations represent a true challenge for harnessing their
therapeutic potential. To address these issues, recent research focuses on
developing innovative drug delivery systems (DDS). These technological
platforms — including liposomes, nanoparticles, hydrogels, and polymeric films
— aim to
stabilize EOs, enhance their targeted delivery, and improve skin
penetration while reducing toxicity.
This study presents an up-to-date
review of the scientific and technological advances in integrating plant
essential oils into next-generation delivery vectors. The objective is to
explore how the convergence between nature and nanoscience can transform EOs
into safe, effective, and intelligently delivered dermatotherapeutic agents.
How to stabilize the volatile power
of essential oils?
This study is based on a
qualitative
analysis of the most commonly used essential oils in dermatology, such as
lavender, tea tree, eucalyptus, rosemary, lemongrass, clove, chamomile, and
turmeric — known for their
antimicrobial, antifungal, anti-inflammatory, and
antioxidant properties. It also examines the
developed formulations,
administration devices, and
delivery systems such as nanoemulsions, liposomes,
solid lipid nanoparticles (SLN), micelles, nanogels, polymeric films, or
sustained-release devices.
The results show that encapsulating
these EOs in nanotechnological carriers leads to
improved physicochemical
stability, prolonged and controlled release, and
enhanced skin penetration.
These formulations also
reduce cytotoxicity and the irritant effects associated
with applying pure EOs. In models of acne, atopic dermatitis, or infected
wounds, nanocarrier-based formulations demonstrated
stronger antimicrobial and
anti-inflammatory activity as well as
accelerated healing.
Some platforms even enable
targeted
delivery to keratinocytes, fibroblasts, or cutaneous immune cells, thereby
optimizing the therapeutic effect while reducing systemic side effects. These
findings confirm the growing interest in nanotechnologies to enhance the
therapeutic potential of EOs in dermatology, ensuring safety, efficacy, and
precision.
Towards smart and natural skincare?
Skin conditions — whether
inflammatory, infectious, or chronic — require effective, safe, and
well-tolerated treatments. Despite their promising therapeutic properties,
plant essential oils face several challenges: chemical instability, poor skin
penetration, and irritant potential when applied pure. The aim of this review
was to
analyze how innovative delivery systems help overcome these limitations
and
optimize the use of EOs in dermatology. The results demonstrate that
encapsulating EOs in nanotechnological vectors significantly improves their
stability, skin tolerance, and therapeutic efficacy, while enabling controlled
and targeted release.
Future perspectives include
standardizing formulations, developing smart delivery systems, and validating
clinical efficacy through randomized trials. Integrating essential oils into
well-designed technological platforms could thus give rise to a
new generation
of dermatological treatments combining natural origin, precision, and
effectiveness.
Read next: Vitamin D and skin: friendly or hostile light?
About the author – Ana EspinoPhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.